{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T09:01:44Z","timestamp":1779958904204,"version":"3.53.1"},"reference-count":74,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T00:00:00Z","timestamp":1779926400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012190","name":"Ministry of Science and Higher Education of the Russian Federation","doi-asserted-by":"publisher","award":["075-15-2025-200\/GTR-G"],"award-info":[{"award-number":["075-15-2025-200\/GTR-G"]}],"id":[{"id":"10.13039\/501100012190","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Adverse drug reactions (ADRs) remain a major public health issue, and genetic factors contribute importantly to interindividual variability in drug response. Pharmacogenetic testing helps reduce ADR risk by optimizing drug selection and dosage, particularly in monogenic disorders. Whole-exome sequencing of 6739 samples from the Russian population was performed on the DNBSEQ-G400 platform (MGI). Variants in 48 genes were examined, focusing on inherited arrhythmias, enzyme deficiencies (Glucose-6-Phosphate Dehydrogenase Deficiency [G6PDD], Porphyrias), Dravet Syndrome (DS) and Malignant Hyperthermia (MH). Variants reported as pathogenic (P), likely pathogenic (LP), or variants of uncertain significance (VUS) in ClinVar were manually re-evaluated using ACMG criteria. A total of 75 unique variants in 18 genes were observed in 119 individuals (1.77%), including 21 carriers and 13 women with a G6PD mutation. Of these, 44 variants were classified as P, 24 as LP, and 7 as VUS. Missense variants accounted for the largest proportion (73.33%). The most affected genes were KCNQ1 (24\/119), which exhibited the highest number of unique variants (18), G6PD (20\/119), SCN1A (15\/119), and RYR1 (14\/119). Regarding associated conditions, mutations linked to arrhythmias were found in 51 individuals, MH in 27, G6PDD in 20, DS in 15, and Porphyrias in 6. Integrating common and rare clinically actionable genetic variants with attention to penetrance and clinical validity may improve medication safety, reduce preventable ADRs, and enhance personalized pharmacotherapy.<\/jats:p>","DOI":"10.3390\/ijms27114851","type":"journal-article","created":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T08:00:36Z","timestamp":1779955236000},"page":"4851","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Monogenic Syndromes as a Cause of Adverse Drug Reactions in the Russian Population"],"prefix":"10.3390","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7894-9222","authenticated-orcid":false,"given":"Anastasiia A.","family":"Buianova","sequence":"first","affiliation":[{"name":"Genomics Laboratory, Pirogov Russian National Research Medical University, 117997 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5294-3033","authenticated-orcid":false,"given":"Valery V.","family":"Cheranev","sequence":"additional","affiliation":[{"name":"Genomics Laboratory, Pirogov Russian National Research Medical University, 117997 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5256-0892","authenticated-orcid":false,"given":"Anna O.","family":"Shmitko","sequence":"additional","affiliation":[{"name":"Genomics Laboratory, Pirogov Russian National Research Medical University, 117997 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iuliia A.","family":"Vasiliadis","sequence":"additional","affiliation":[{"name":"Genomics Laboratory, Pirogov Russian National Research Medical University, 117997 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-8941-7034","authenticated-orcid":false,"given":"Alina F.","family":"Samitova","sequence":"additional","affiliation":[{"name":"Genomics Laboratory, Pirogov Russian National Research Medical University, 117997 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6974-2921","authenticated-orcid":false,"given":"Oleg N.","family":"Suchalko","sequence":"additional","affiliation":[{"name":"Genomics Laboratory, Pirogov Russian National Research Medical University, 117997 Moscow, Russia"},{"name":"Abu Dhabi Stem Cells Center, Abu Dhabi P.O. Box 4600, United Arab Emirates"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-4228-6114","authenticated-orcid":false,"given":"Zhanna A.","family":"Repinskaia","sequence":"additional","affiliation":[{"name":"Genomics Laboratory, Pirogov Russian National Research Medical University, 117997 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikhail Iu.","family":"Kuznetsov","sequence":"additional","affiliation":[{"name":"Genomics Laboratory, Pirogov Russian National Research Medical University, 117997 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5930-1965","authenticated-orcid":false,"given":"Vera A.","family":"Belova","sequence":"additional","affiliation":[{"name":"Genomics Laboratory, Pirogov Russian National Research Medical University, 117997 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1343-2550","authenticated-orcid":false,"given":"Dmitriy O.","family":"Korostin","sequence":"additional","affiliation":[{"name":"Genomics Laboratory, Pirogov Russian National Research Medical University, 117997 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,5,28]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1002\/cpt.3701","article-title":"FDA Adverse Event Reporting System (FAERS) Essentials: A Guide to Understanding, Applying, and Interpreting Adverse Event Data Reported to FAERS","volume":"118","author":"Potter","year":"2025","journal-title":"Clin. Pharmacol. Ther."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1023\/A:1015570104121","article-title":"Hospitalisations caused by adverse drug reactions (ADR): A meta-analysis of observational studies","volume":"24","author":"Beijer","year":"2002","journal-title":"Pharmacol. World Sci."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"6058","DOI":"10.1038\/s41598-024-56855-z","article-title":"Prevalence of Urgent Hospitalizations Caused by Adverse Drug Reactions: A Cross-Sectional Study","volume":"14","author":"Komagamine","year":"2024","journal-title":"Sci. Rep."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Zhai, J., Yan, H., Zhang, J., Yan, H., Ma, J., and Zhang, S. (2025). A Comprehensive Analysis of Adverse Drug Reactions in 2020\u20132023: Case Studies. Front. Pharmacol., 16.","DOI":"10.3389\/fphar.2025.1628347"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"4334","DOI":"10.1111\/bcp.14851","article-title":"Fatal Adverse Drug Reactions: A Worldwide Perspective in the World Health Organization Pharmacovigilance Database","volume":"87","author":"Montastruc","year":"2021","journal-title":"Br. J. Clin. Pharmacol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"e71519","DOI":"10.2196\/71519","article-title":"Visualization of FDA Adverse Drug Reaction Reports: Development and Usability Study of the VisDrugs Web Server","volume":"9","author":"Yang","year":"2025","journal-title":"JMIR Form. Res."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"De La Torre, B.G., and Albericio, F. (2025). The Pharmaceutical Industry in 2024: An Analysis of the FDA Drug Approvals from the Perspective of Molecules. Molecules, 30.","DOI":"10.20944\/preprints202501.0253.v1"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1002\/cpt.2122","article-title":"Pharmacogenetics at Scale: An Analysis of the UK Biobank","volume":"109","author":"McInnes","year":"2021","journal-title":"Clin. Pharmacol. Ther."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1002\/cpt.1568","article-title":"Pharmacogenomics Clinical Annotation Tool (Pharm CAT)","volume":"107","author":"Sangkuhl","year":"2020","journal-title":"Clin. Pharmacol. Ther."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Micaglio, E., Locati, E.T., Monasky, M.M., Romani, F., Heilbron, F., and Pappone, C. (2021). Role of Pharmacogenetics in Adverse Drug Reactions: An Update towards Personalized Medicine. Front. Pharmacol., 12.","DOI":"10.3389\/fphar.2021.651720"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Nakano, M., Funayama, M., Takata, T., Wakisaka, R., Koyama, G., Koreki, A., Ishida, T., Uchida, H., and Mimura, M. (2024). Caution for Psychiatrists: Malignant Hyperthermia Risks with the Anesthetic Agent Succinylcholine (Suxamethonium) during Electroconvulsive Therapy. BMC Psychiatry, 24.","DOI":"10.1186\/s12888-024-05846-5"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"e003133","DOI":"10.1161\/CIRCGEN.120.003133","article-title":"KCNQ1 and Long QT Syndrome in 1\/45 Amish: The Road From Identification to Implementation of Culturally Appropriate Precision Medicine","volume":"13","author":"Streeten","year":"2020","journal-title":"Circ. Genom. Precis. Med."},{"key":"ref_13","unstructured":"(2025, December 13). CredibleMeds: QTdrugs List\/\/AZCERT, Inc.\u2014Last Updated: 7 November 2025. Available online: https:\/\/crediblemeds.org."},{"key":"ref_14","unstructured":"BrugadaDrugs.org (2025, December 14). Safe Drug Use and the Brugada Syndrome. Available online: https:\/\/www.brugadadrugs.org\/."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1002\/cpt.1319","article-title":"Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for the Use of Potent Volatile Anesthetic Agents and Succinylcholine in the Context of RYR 1 or CACNA 1S Genotypes","volume":"105","author":"Gonsalves","year":"2019","journal-title":"Clin. Pharmacol. Ther."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0735-1097(02)01946-0","article-title":"Screening for Ryanodine Receptor Type 2 Mutations in Families with Effort-Induced Polymorphic Ventricular Arrhythmias and Sudden Death","volume":"40","author":"Bauce","year":"2002","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"e200352","DOI":"10.1212\/NXG.0000000000200352","article-title":"Elicited Repetitive Daily Blindness Associated With Gain-of-Function SCN1A Variants and Responsiveness to Sodium Channel Blockers","volume":"12","author":"Harper","year":"2026","journal-title":"Neurol. Genet."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"e00476","DOI":"10.1002\/mgg3.476","article-title":"Penetrance and Expressivity of the R858H CACNA1C Variant in a Five-generation Pedigree Segregating an Arrhythmogenic Channelopathy","volume":"7","author":"Gardner","year":"2019","journal-title":"Mol. Genet. Genom. Med."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1161\/CIRCULATIONAHA.119.043114","article-title":"An International Multicenter Evaluation of Type 5 Long QT Syndrome: A Low Penetrant Primary Arrhythmic Condition","volume":"141","author":"Roberts","year":"2020","journal-title":"Circulation"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1002\/mgg3.305","article-title":"Autosomal Recessive Long QT Syndrome, Type 1 in Eight Families from Saudi Arabia","volume":"5","author":"Bdier","year":"2017","journal-title":"Mol. Genet. Genom. Med."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1017\/S1047951115001304","article-title":"Genotype-Based Clinical Manifestation and Treatment of Chinese Long QT Syndrome Patients with KCNQ1 Mutations\u2014R380S and W305L","volume":"26","author":"Zhou","year":"2016","journal-title":"Cardiol. Young"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1034\/j.1399-0004.2003.00048.x","article-title":"KCNQ1 Mutations in Patients with a Family History of Lethal Cardiac Arrhythmias and Sudden Death","volume":"63","author":"Chen","year":"2003","journal-title":"Clin. Genet."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"126","DOI":"10.15836\/ccar2024.126","article-title":"Familial Long QT Syndrome: A Case Report","volume":"19","author":"Ereiz","year":"2023","journal-title":"Cardiol. Croat."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"3129","DOI":"10.1038\/s41598-018-21442-6","article-title":"A hERG Mutation E1039X Produced a Synergistic Lesion on IKs Together with KCNQ1-R174C Mutation in a LQTS Family with Three Compound Mutations","volume":"8","author":"Wu","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_25","unstructured":"(2025, December 13). Table of Pharmacogenomic Biomarkers in Drug Labeling\/\/U.S. Food and Drug Administration (FDA).\u2014Last Updated: 23 September 2024, Available online: https:\/\/www.fda.gov\/drugs\/science-and-research-drugs\/table-pharmacogenomic-biomarkers-drug-labeling."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1093\/bioinformatics\/bty897","article-title":"VarSome: The Human Genomic Variant Search Engine","volume":"35","author":"Kopanos","year":"2019","journal-title":"Bioinformatics"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1002\/cpt.891","article-title":"Comprehensive Pharmacogenomic Study Reveals an Important Role of UGT1A3 in Montelukast Pharmacokinetics","volume":"104","author":"Hirvensalo","year":"2018","journal-title":"Clin. Pharmacol. Ther."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"215","DOI":"10.2147\/TACG.S55762","article-title":"Genetics of Inherited Primary Arrhythmia Disorders","volume":"8","author":"Gollob","year":"2015","journal-title":"Appl. Clin. Genet."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"e038308","DOI":"10.1161\/JAHA.124.038308","article-title":"Catecholaminergic Polymorphic Ventricular Tachycardia: Advancing From Molecular Insights to Preclinical Models","volume":"14","author":"Schneider","year":"2025","journal-title":"J. Am. Heart Assoc."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1097\/PCC.0000000000001847","article-title":"Catecholaminergic Polymorphic Ventricular Tachycardia: The Cardiac Arrest Where Epinephrine Is Contraindicated*","volume":"20","author":"Bellamy","year":"2019","journal-title":"Pediatr. Crit. Care Med."},{"key":"ref_31","first-page":"100786","article-title":"Atrial Fibrillation: Epidemiology, Screening and Digital Health","volume":"37","author":"Linz","year":"2024","journal-title":"Lancet Reg. Health-Eur."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"107077","DOI":"10.1016\/j.phrs.2024.107077","article-title":"Drug-Induced Atrial Fibrillation. A Narrative Review of a Forgotten Adverse Effect","volume":"200","author":"Tamargo","year":"2024","journal-title":"Pharmacol. Res."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1161\/CIRCULATIONAHA.109.863209","article-title":"Prevalence of the Congenital Long-QT Syndrome","volume":"120","author":"Schwartz","year":"2009","journal-title":"Circulation"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1080\/00365510701765643","article-title":"Molecular Genetic Analysis of Long QT Syndrome in Norway Indicating a High Prevalence of Heterozygous Mutation Carriers","volume":"68","author":"Berge","year":"2008","journal-title":"Scand. J. Clin. Lab. Investig."},{"key":"ref_35","first-page":"50","article-title":"Prevalence and risk Factors for long QT interval Syndrome in Patients of the City Psychiatric hospital","volume":"3","author":"Malin","year":"2023","journal-title":"Mod. Ther. Ment. Disord."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Zaklyazminskaya, E.V., and Abriel, H. (2012). Prevalence of Significant Genetic Variants in Congenital Long QT Syndrome Is Largely Underestimated. Front. Pharmacol., 3.","DOI":"10.3389\/fphar.2012.00072"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.1016\/j.jacep.2024.07.022","article-title":"Clinical Features, Long-Term Prognosis, and Clinical Management of Genotype-Negative Long QT Syndrome Patients","volume":"10","author":"Shimamoto","year":"2024","journal-title":"JACC Clin. Electrophysiol."},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Boulmpou, A., Giannopoulos, A., Papadopoulos, C., Giannopoulos, G., Papagiannis, I., Zormpas, G., Keivanidou, A., Fidani, L., and Vassilikos, V. (2025). The Uncommon Phenomenon of Short QT Syndrome: A Scoping Review of the Literature. J. Pers. Med., 15.","DOI":"10.3390\/jpm15030105"},{"key":"ref_39","first-page":"267","article-title":"Worldwide Prevalence of Brugada Syndrome: A Systematic Review and Meta-Analysis","volume":"34","author":"Vutthikraivit","year":"2018","journal-title":"Acta Cardiol. Sin."},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Xu, T., Wang, S., Wang, J., and Xing, J. (2025). Brugada Syndrome Update. Front. Physiol., 15.","DOI":"10.3389\/fphys.2024.1520008"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"11","DOI":"10.4103\/ACCJ.ACCJ_10_22","article-title":"Differences in the Rate and Yield of Genetic Testing in Patients With Brugada Syndrome: A Systematic Review and Analysis of Cohort Studies","volume":"5","author":"Chung","year":"2023","journal-title":"Ann. Clin. Cardiol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"102566","DOI":"10.1016\/j.cpcardiol.2024.102566","article-title":"Brugada Phenocopy vs. Brugada Syndrome: Delineating the Differences for Optimal Diagnosis and Management","volume":"49","author":"Adytia","year":"2024","journal-title":"Curr. Probl. Cardiol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"3870","DOI":"10.1016\/S0735-1097(23)04314-0","article-title":"Genotypic Overlap Between Brugada Syndrome and Hypertrophic Cardiomyopathy or Brugada Phenocopy?","volume":"81","author":"Leelaviwat","year":"2023","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s42444-024-00121-w","article-title":"Clinical Role of Genetic Testing for the Brugada Syndrome Overlapping with Arrhythmogenic Cardiomyopathy","volume":"25","author":"Jeong","year":"2024","journal-title":"Int. J. Arrhythm."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.joa.2015.10.007","article-title":"An Overlap of Brugada Syndrome and Arrhythmogenic Right Ventricular Cardiomyopathy\/Dysplasia","volume":"32","author":"Kataoka","year":"2016","journal-title":"J. Arrhythm."},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Saha, A.K., and Pinyavat, T. (2025). Genetic Testing for Malignant Hyperthermia Susceptibility\u2014Threading the Needle in the Haystack. Genes, 16.","DOI":"10.20944\/preprints202508.1695.v1"},{"key":"ref_47","first-page":"001","article-title":"STAC3 Gene Congenital Myopathy and Malignant Hyperthermia: A Crossroads between Neurology and Anesthesia","volume":"83","author":"Silva","year":"2025","journal-title":"Arq. Neuropsiquiatr."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1016\/j.bja.2018.06.028","article-title":"Genetic Epidemiology of Malignant Hyperthermia in the UK","volume":"121","author":"Miller","year":"2018","journal-title":"Br. J. Anaesth."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1097\/ALN.0000000000002813","article-title":"An Assessment of Penetrance and Clinical Expression of Malignant Hyperthermia in Individuals Carrying Diagnostic Ryanodine Receptor 1 Gene Mutations","volume":"131","author":"Hu","year":"2019","journal-title":"Anesthesiology"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.bja.2025.11.006","article-title":"European Malignant Hyperthermia Group 2025 Guidelines for the Investigation of Malignant Hyperthermia Susceptibility","volume":"136","author":"Gillies","year":"2026","journal-title":"Br. J. Anaesth."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1111\/epi.17866","article-title":"A Systematic Literature Review on the Global Epidemiology of Dravet Syndrome and Lennox\u2013Gastaut Syndrome: Prevalence, Incidence, Diagnosis, and Mortality","volume":"65","author":"Sullivan","year":"2024","journal-title":"Epilepsia"},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Gao, C., Pielas, M., Jiao, F., Mei, D., Wang, X., Kotulska, K., and Jozwiak, S. (2023). Epilepsy in Dravet Syndrome\u2014Current and Future Therapeutic Opportunities. J. Clin. Med., 12.","DOI":"10.3390\/jcm12072532"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.ejpn.2019.02.014","article-title":"Burden-of-Illness and Cost-Driving Factors in Dravet Syndrome Patients and Carers: A Prospective, Multicenter Study from Germany","volume":"23","author":"Strzelczyk","year":"2019","journal-title":"Eur. J. Paediatr. Neurol."},{"key":"ref_54","first-page":"17","article-title":"Porphyria Diagnostics\u2014Part 1: A Brief Overview of the Porphyrias","volume":"86","author":"Ramanujam","year":"2015","journal-title":"Curr. Protoc. Hum. Genet."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"164","DOI":"10.4103\/jpgm.jpgm_698_22","article-title":"Porphyrias: Uncommon Disorders Masquerading as Common Childhood Diseases","volume":"69","author":"Chakraborty","year":"2023","journal-title":"J. Postgrad. Med."},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Yu, Z., Xiong, Q., Wang, Z., Li, L., and Niu, T. (2025). Global, Regional, and National Burden of Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency from 1990 to 2021: A Systematic Analysis of the Global Burden of Disease Study 2021. Front. Genet., 16.","DOI":"10.3389\/fgene.2025.1593728"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1038\/s41598-021-04526-8","article-title":"System Analysis of the Sequencing Quality of Human Whole Exome Samples on BGI NGS Platform","volume":"12","author":"Belova","year":"2022","journal-title":"Sci. Rep."},{"key":"ref_58","unstructured":"Andrews, S. (2025, November 20). FastQC: A Quality Control Tool for High Throughput Sequence Data. Available online: http:\/\/www.bioinformatics.babraham.ac.uk\/projects\/fastqc\/."},{"key":"ref_59","unstructured":"(2025, April 20). Joint Genome Institute, Available online: https:\/\/jgi.doe.gov\/data-and-tools\/software-tools\/bbtools\/bb-tools-user-guide\/bbduk-guide\/."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1093\/bioinformatics\/btp324","article-title":"Fast and Accurate Short Read Alignment with Burrows\u2013Wheeler Transform","volume":"25","author":"Li","year":"2009","journal-title":"Bioinformatics"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1093\/bioinformatics\/btp352","article-title":"1000 Genome Project Data Processing Subgroup The Sequence Alignment\/Map Format and SAMtools","volume":"25","author":"Li","year":"2009","journal-title":"Bioinformatics"},{"key":"ref_62","unstructured":"(2025, April 20). Picard Toolkit, Available online: https:\/\/broadinstitute.github.io\/picard\/."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"2987","DOI":"10.1093\/bioinformatics\/btr509","article-title":"A Statistical Framework for SNP Calling, Mutation Discovery, Association Mapping and Population Genetical Parameter Estimation from Sequencing Data","volume":"27","author":"Li","year":"2011","journal-title":"Bioinformatics"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1038\/nbt.4235","article-title":"A Universal SNP and Small-Indel Variant Caller Using Deep Neural Networks","volume":"36","author":"Poplin","year":"2018","journal-title":"Nat. Biotechnol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/s13059-016-0974-4","article-title":"The Ensembl Variant Effect Predictor","volume":"17","author":"McLaren","year":"2016","journal-title":"Genome Biol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"3047","DOI":"10.1093\/bioinformatics\/btw354","article-title":"MultiQC: Summarize Analysis Results for Multiple Tools and Samples in a Single Report","volume":"32","author":"Ewels","year":"2016","journal-title":"Bioinformatics"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and Guidelines for the Interpretation of Sequence Variants: A Joint Consensus Recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet. Med."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/nbt.1754","article-title":"Integrative Genomics Viewer","volume":"29","author":"Robinson","year":"2011","journal-title":"Nat. Biotechnol."},{"key":"ref_69","unstructured":"(2025, December 13). Online Mendelian Inheritance in Man, OMIM\u00ae. Available online: https:\/\/omim.org\/."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1016\/j.gim.2022.04.017","article-title":"The Gene Curation Coalition: A Global Effort to Harmonize Gene\u2013Disease Evidence Resources","volume":"24","author":"DiStefano","year":"2022","journal-title":"Genet. Med."},{"key":"ref_71","doi-asserted-by":"crossref","unstructured":"Liu, H., Chatel, S., Simard, C., Syam, N., Salle, L., Probst, V., Morel, J., Millat, G., Lopez, M., and Abriel, H. (2013). Molecular Genetics and Functional Anomalies in a Series of 248 Brugada Cases with 11 Mutations in the TRPM4 Channel. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0054131"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"4087","DOI":"10.1093\/hmg\/ddac145","article-title":"Updated Variant Curation Expert Panel Criteria and Pathogenicity Classifications for 251 Variants for RYR1-Related Malignant Hyperthermia Susceptibility","volume":"31","author":"Johnston","year":"2022","journal-title":"Hum. Mol. Genet."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ajhg.2023.01.003","article-title":"Functional Interpretation, Cataloging, and Analysis of 1,341 Glucose-6-Phosphate Dehydrogenase Variants","volume":"110","author":"Geck","year":"2023","journal-title":"Am. J. Hum. Genet."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1161\/CIRCRESAHA.123.323029","article-title":"Loss of the Atrial Fibrillation-Related Gene, Zfhx3, Results in Atrial Dilation and Arrhythmias","volume":"133","author":"Jameson","year":"2023","journal-title":"Circ. Res."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/11\/4851\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T08:03:03Z","timestamp":1779955383000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/11\/4851"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,28]]},"references-count":74,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2026,6]]}},"alternative-id":["ijms27114851"],"URL":"https:\/\/doi.org\/10.3390\/ijms27114851","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,28]]}}}